<DOC>
	<DOC>NCT00948220</DOC>
	<brief_summary>One single study has suggested that bone mineral density (BMD) is reduced in patients with non-cirrhotic chronic viral hepatitis C. Antiviral combination therapy with standard interferon and ribavirin may further decrease BMD. The aim of this study is to systematically investigate the effect of chronic hepatitis C genotype 1 infection alone and current standard therapy with peginterferon alfa-2a/ribavirin on BMD and bone metabolism.</brief_summary>
	<brief_title>Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>proven chronic hepatitis C aged between 18 and 65 male patients high grade liver fibrosis (Grade 3 4) renal disease hyperparathyroidism hypogonadism malignant disease use of any other drug known to effect bone mineral metabolism use of alcohol organ transplant any form of thyroid disease any medical condition known to be associated with bone loss</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>HCV</keyword>
	<keyword>hepatitis C virus</keyword>
	<keyword>CHC</keyword>
	<keyword>chronic hepatitis c</keyword>
	<keyword>interferon</keyword>
	<keyword>ribavirin</keyword>
	<keyword>DEXA</keyword>
	<keyword>BMD</keyword>
	<keyword>bone mineral density</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>osteopenia</keyword>
	<keyword>osteodystrophy</keyword>
	<keyword>osteodensitometry</keyword>
	<keyword>Bone Density</keyword>
	<keyword>Hepatitis, Viral, Human</keyword>
	<keyword>Anti-Infective Agents</keyword>
	<keyword>peginterferon alfa-2a</keyword>
</DOC>